An ethnomedical study of the role and impact of cannabidiol (CBD) treatment of women living with endometriosis and Polycystic Ovarian Syndrome (PCOS)

Abstract

Over the last few years, there has been a notable increase in popularity in the use of cannabidiol (CBD) as a form of alternative medicinal treatment for various illnesses. CBD, a by-product of the cannabis plant, is an isolate and does not contain the psychoactive agent, tetrahydrocannabinol (THC). Endometriosis and Polycystic Ovarian Syndrome (PCOS) are chronic reproductive health sicknesses that are increasingly experienced by women. In the absence of cures, biomedical treatment for these diseases aim to manage symptoms, for example; heavy bleeding, heightened levels of pain, and insomnia. CBD offers an alternative to women who feel that biomedical interventions are no longer able to maintain their health and well-being. CBD positions itself as a natural remedy claiming to be safe and effective. This research study, mainly through qualitative data collection, focused on experiences of Zimbabwean and South African women living with endometriosis and/ or PCOS, who have turned to CBD to manage their symptoms. The importance of this study was to position itself within patients' lived experiences. The research study found that CBD indeed has numerous benefits, including pain management, alleviating stress, and anxiety. Through the emergent themes from the data, it became clear that women are marginalised and treated unequally in the biomedical healthcare sphere. Feminist Anthropology and Structural Violence was applied to analyse the data collected to explore the patriarchal nature of the biomedical healthcare system and the experiences that women have, which has led them to turn to alternative treatments.